Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Revenue (2016 - 2025)

Icu Medical (ICUI) has disclosed Revenue for 17 consecutive years, with $540.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 14.15% year-over-year to $540.7 million, compared with a TTM value of $2.2 billion through Dec 2025, down 6.33%, and an annual FY2025 reading of $2.2 billion, down 6.33% over the prior year.
  • Revenue was $540.7 million for Q4 2025 at Icu Medical, up from $537.0 million in the prior quarter.
  • Across five years, Revenue topped out at $629.8 million in Q4 2024 and bottomed at $318.0 million in Q1 2021.
  • Average Revenue over 5 years is $523.4 million, with a median of $557.2 million recorded in 2022.
  • The sharpest move saw Revenue surged 77.9% in 2022, then fell 14.15% in 2025.
  • Year by year, Revenue stood at $340.5 million in 2021, then skyrocketed by 69.74% to $578.0 million in 2022, then grew by 1.7% to $587.9 million in 2023, then grew by 7.14% to $629.8 million in 2024, then dropped by 14.15% to $540.7 million in 2025.
  • Business Quant data shows Revenue for ICUI at $540.7 million in Q4 2025, $537.0 million in Q3 2025, and $548.9 million in Q2 2025.